SXTC (China SXT Pharmaceuticals) ROE % Adjusted to Book Value: -7.93% (As of Sep. 2025)


SXTC China SXT Pharmaceuticals Inc SXTC
26 GF Score
Price $2.41
! 5 Warning Signs
View Full Analysis

What is China SXT Pharmaceuticals ROE % Adjusted to Book Value?

China SXT Pharmaceuticals SXTC +2.98% 26 ROE % Adjusted to Book Value is -7.93% as of Sep. 2025. GuruFocus rates SXTC with a GF Score™ of 26/100. The stock has 5 warning signs investors should review.

China SXT Pharmaceuticals's ROE % for the quarter that ended in Sep. 2025 was -71.41%. China SXT Pharmaceuticals's PB Ratio for the quarter that ended in Sep. 2025 was 9.01. China SXT Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2025 was -7.93%.

China SXT Pharmaceuticals ROE % Adjusted to Book Value Related Terms

China SXT Pharmaceuticals ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for China SXT Pharmaceuticals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China SXT Pharmaceuticals ROE % Adjusted to Book Value Chart

China SXT Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 -74.69 -10.09

China SXT Pharmaceuticals Semi-Annual Data
Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -268.78 478.83 -51.23 -17.51 -7.93

SXTC vs YCBD, CVSI, INM: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China SXT Pharmaceuticals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China SXT Pharmaceuticals ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China SXT Pharmaceuticals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where China SXT Pharmaceuticals's ROE % Adjusted to Book Value falls into.


SXTC
26GF Score
China SXT Pharmaceuticals Inc SXTC
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China SXT Pharmaceuticals ROE % Adjusted to Book Value Calculation

China SXT Pharmaceuticals's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-22.50% / 2.23
=-10.09%

China SXT Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-71.41% / 9.01
=-7.93%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -7.93% mean?
China SXT Pharmaceuticals (SXTC) has a ROE % Adjusted to Book Value of -7.93% as of Sep. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on China SXT Pharmaceuticals and its competitors.
Is China SXT Pharmaceuticals' ROE % Adjusted to Book Value too high?
China SXT Pharmaceuticals' current ROE % Adjusted to Book Value is -7.93%. Overall, China SXT Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does China SXT Pharmaceuticals' ROE % Adjusted to Book Value compare to YCBD and CVSI?
China SXT Pharmaceuticals' ROE % Adjusted to Book Value of -7.93% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on China SXT Pharmaceuticals and its competitors. China SXT Pharmaceuticals's current ROE % Adjusted to Book Value is -7.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China SXT Pharmaceuticals stock overvalued right now?
China SXT Pharmaceuticals (SXTC) has a current ROE % Adjusted to Book Value of -7.93%. The current ROE % Adjusted to Book Value is -7.93%. China SXT Pharmaceuticals' overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For China SXT Pharmaceuticals (SXTC), the current ROE % Adjusted to Book Value is -7.93% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

China SXT Pharmaceuticals Business Description

Address No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
26GF Score

Get the complete analysis for SXTC

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.41
Price